BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Pancreas
,
Nosology
,
Doxycycline
,
rs4950928
,
IGF1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
KCNQ2
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Amygdala
Cerebellum
Hippocampus
Cerebellar vermis
Cerebellar hemisphere
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Blindness AND/OR vision impairment level
Epilepsy
Festuca arundinacea poisoning
Brain cancer
Huntington's disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Imidazoles
Inosine
marinobufagenin
TGX 221
5-azacytosine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
YBX2
BCL10
TYROBP
ANGPT1
PINK1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical characteristics of KCNQ2 encephalopathy.
Molecular basis for ligand activation of the human KCNQ2 channel.
Ethanol inhibits Kv7.2/7.3 channel open probability by reducing the PI(4,5)P2 sensitivity of Kv7.2 s…
Ictal and interictal electroencephalographic findings can contribute to early diagnosis and prompt t…
Heteromeric Kv7.2 current changes caused by loss-of-function of KCNQ2 mutations are correlated with …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
Study to Treat Major Depressive Disorder With a New Medication
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
Molecular Genetics in Infantile Spasms
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ